Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT)
Vincent Piguet, Andrew Blauvelt, Daniel Burge, Luke Peterson, Janice Drew, Robert Rolleri, Jolanta Weglowska
Abstract Not Available
Disclosure: Study supported by Dermira.
psoriasis; certolizumab; randomized trial; multicenter
Abstract - 263 Poster PDF - 92
- There are currently no refbacks.